Insider · CIK 0001320267

Daly David

Reports to the SEC for 4 companies · ALISO VIEJO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001320267

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-10	NEONEOGENOMICS INCA Award	Director	AAward	+15.6K sh	—	—	17,179
2022-06-10	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,882
2022-03-04	Singular Genomics Systems, Inc.Employee Stock Option (right to buy)A Award	President and Chief Operating	AAward	+125K sh	—	—	0
2022-03-04	Singular Genomics Systems, Inc.Employee Stock Option (right to buy)A Award	President and Chief Operating	AAward	+125K sh	—	—	0
2021-11-10	NEONEOGENOMICS INCA Award	Director	AAward	+1,623 sh	—	—	1,623
2021-11-10	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+1,945 sh	—	—	1,945
2017-08-09	Foundation Medicine, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+46.9K sh	$22.24	+$1.04M	163,133
2017-08-09	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−46.9K sh	$39.50	−$1.85M	116,261
2017-08-09	Foundation Medicine, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−46.9K sh	—	—	28,128
2017-07-06	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,452 sh	$38.84	−$95.2K	117,296
2017-07-06	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−1,035 sh	$38.84	−$40.2K	116,261
2017-07-06	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,829 sh	$38.84	−$110K	119,748
2017-06-01	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−555 sh	$38.30	−$21.3K	122,577
2017-05-01	Foundation Medicine, Inc.A Award	Chief Commercial Officer	AAward	+24.6K sh	$35.80	+$879K	123,132
2017-04-03	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,070 sh	$31.96	−$66.2K	98,582
2017-03-01	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−541 sh	$25.12	−$13.6K	100,652
2017-01-04	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,370 sh	$18.49	−$43.8K	101,193
2017-01-03	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,727 sh	$17.41	−$47.5K	103,563
2016-12-01	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−564 sh	$19.95	−$11.3K	106,290
2016-10-04	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,045 sh	$23.65	−$48.4K	106,854
2016-09-01	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−551 sh	$20.48	−$11.3K	108,899
2016-07-05	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,130 sh	$18.26	−$38.9K	109,450
2016-07-01	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,878 sh	$17.39	−$50K	111,580
2016-06-03	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−472 sh	$21.66	−$10.2K	114,458
2016-04-01	Foundation Medicine, Inc.A Award	Chief Commercial Officer	AAward	+70K sh	$18.25	+$1.28M	114,930
2016-03-01	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−701 sh	$15.14	−$10.6K	44,930
2015-12-01	Foundation Medicine, Inc.S Sale	Chief Commercial Officer	SSale	−2,559 sh	$16.78	−$42.9K	45,631
2015-07-15	Foundation Medicine, Inc.A Award	Chief Commercial Officer	AAward	+23.2K sh	$32.74	+$759K	48,190
2015-02-03	Foundation Medicine, Inc.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+75K sh	—	—	75,000
2014-12-05	Foundation Medicine, Inc.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+75K sh	—	—	75,000
2014-12-05	Foundation Medicine, Inc.A Award	Chief Commercial Officer	AAward	+25K sh	$22.24	+$556K	25,000
2010-12-22	CLARIENT, INCClarient, Inc. stock option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+20K sh	$3.88	+$77.6K	0
2010-12-22	CLARIENT, INCClarient, Inc. stock option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+50K sh	$2.90	+$145K	0
2010-12-22	CLARIENT, INCD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−158K sh	$5.00	−$792K	0
2010-12-22	CLARIENT, INCClarient, Inc. stock option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+75K sh	$3.51	+$263K	0
2010-12-17	CLARIENT, INCU Disposition from Tender	Chief Commercial Officer	UDisposition from Tender	+96K sh	$5.00	+$480K	158,334
2010-06-08	CLARIENT, INCA Award	Chief Commercial Officer	AAward	+100K sh	—	—	254,309
2010-06-01	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,600 sh	$2.96	−$4,736	154,309
2010-05-03	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,810 sh	$3.17	−$5,737.7	155,909
2010-04-05	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,575 sh	$2.66	−$4,189.5	157,719
2010-03-01	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−2,100 sh	$1.96	−$4,116	159,294
2010-02-04	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,950 sh	$2.21	−$4,309.5	161,394
2010-01-05	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,850 sh	$2.72	−$5,032	163,344
2009-12-02	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,750 sh	$2.43	−$4,252.5	165,194
2009-11-03	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,675 sh	$3.09	−$5,175.75	166,944
2009-10-05	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,540 sh	$4.15	−$6,391	168,619
2009-09-03	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,525 sh	$4.05	−$6,176.25	170,159
2009-08-06	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−1,565 sh	$3.74	−$5,853.1	171,735
2009-08-06	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−51 sh	$3.75	−$191.25	171,684
2009-07-13	CLARIENT, INCS Sale	Chief Commercial Officer	SSale	−25K sh	$3.28	−$82K	173,300

Recent filings

Accepted (ET)
Jun 144
Daly David0001077183-22-000108
SEC(opens sec.gov)
Mar 84
Daly David0001209191-22-017287
SEC(opens sec.gov)
Nov 124
Daly David0001077183-21-000247
SEC(opens sec.gov)
Aug 104
Daly David0001209191-17-048408
SEC(opens sec.gov)
Jul 74
Foundation Medicine, Inc.0001209191-17-044354
SEC(opens sec.gov)
Jun 54
Foundation Medicine, Inc.0001209191-17-037656
SEC(opens sec.gov)
May 34
Foundation Medicine, Inc.0001209191-17-029595
SEC(opens sec.gov)
Apr 54
Foundation Medicine, Inc.0001209191-17-025569
SEC(opens sec.gov)
Mar 34
Foundation Medicine, Inc.0001209191-17-017389
SEC(opens sec.gov)
Jan 54
Foundation Medicine, Inc.0001209191-17-001959
SEC(opens sec.gov)
Dec 54
Foundation Medicine, Inc.0001209191-16-153308
SEC(opens sec.gov)
Oct 54
Foundation Medicine, Inc.0001209191-16-144862
SEC(opens sec.gov)

Companies

Address

31 COLUMBIA

ALISO VIEJO, CA, 92656